<DOC>
	<DOC>NCT00561730</DOC>
	<brief_summary>The aim of the study was to evaluate the effect of 7 days treatment with Pantoprazole 40 mg and 20 mg on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) in clinical practice. During the study, the patients had to complete a short version of a patient-orientated, self-assessed reflux questionnaire (ReQuestâ„¢ in Practice).</brief_summary>
	<brief_title>Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Main inclusion criteria: Outpatients with erosive gastroesophageal reflux disease (eGERD according to Los Angeles classification grade AD) or nonerosive reflux disease (NERD) Main exclusion criteria: Criteria as defined in the Summary of Product Characteristics (Chapter 4.3)</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>PPI (Proton Pump Inhibitor) therapy</keyword>
	<keyword>Pantoprazole</keyword>
	<keyword>eGERD (Erosive Gastroesophageal Reflux Disease)</keyword>
	<keyword>NERD (Non-Erosive Reflux Disease)</keyword>
</DOC>